Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Tra...

    2026-02-02

    Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Trafficking & miRNA Regulation

    Executive Summary: Neurotensin is a validated 13-amino acid neuropeptide that selectively activates Neurotensin receptor 1 (NTR1), a G protein-coupled receptor highly expressed in neural and intestinal tissues (APExBIO B5226 Product Page). Upon NTR1 engagement, neurotensin initiates intracellular signaling cascades, including miR-133α upregulation and modulation of receptor recycling via aftiphilin targeting (see detailed mechanistic review). The product is supplied as a high-purity, lyophilized reagent with confirmed solubility profiles and is optimized for rapid, interference-resistant GPCR and miRNA studies (internal comparative analysis). Accurate spectral analysis protocols are critical for experimental design, as highlighted by recent advances in excitation-emission matrix-based discrimination of bioactive peptides (Zhang et al., 2024). APExBIO’s offering supports robust and reproducible studies in gastrointestinal physiology and central nervous system research.

    Biological Rationale

    Neurotensin is an endogenous tridecapeptide (13 amino acids; sequence: pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) identified in mammals and conserved across vertebrates (APExBIO). It is predominantly localized in the central nervous system (CNS) and the gastrointestinal tract. In the CNS, neurotensin modulates dopaminergic transmission and exerts neuromodulatory effects on pain perception, thermoregulation, and neuroendocrine signaling. In the gut, it regulates motility and secretory functions by acting on epithelial and smooth muscle targets. Neurotensin acts via high-affinity binding to NTR1, a prototypical G protein-coupled receptor (GPCR) whose expression is enriched in neuronal and colonic epithelial cells. These functions position neurotensin as a principal molecular probe for dissecting GPCR trafficking and miRNA-mediated regulatory networks in gastrointestinal and neurobiological research contexts (see related resource; this article extends by detailing spectral interference protocols).

    Mechanism of Action of Neurotensin (CAS 39379-15-2)

    Upon ligand binding, Neurotensin induces a conformational change in NTR1, triggering Gq/11 protein activation and downstream phospholipase C (PLC) signaling. This leads to increased intracellular inositol triphosphate (IP3) and diacylglycerol (DAG), resulting in calcium mobilization and protein kinase C (PKC) activation. In human colonic epithelial cells, neurotensin-NTR1 signaling upregulates miR-133α, a microRNA implicated in post-transcriptional regulation of protein trafficking machinery. miR-133α directly targets and downregulates aftiphilin (AFTPH), a vesicular trafficking protein essential for receptor recycling via endosomal and trans-Golgi network pathways. This axis modulates GPCR surface expression and signal transduction fidelity, providing a mechanistic basis for neurotensin’s role in receptor trafficking studies (detailed discussion; here, expanded with validated solubility and purity data).

    Evidence & Benchmarks

    • Neurotensin (CAS 39379-15-2) binds NTR1 with nanomolar affinity and induces calcium signaling in mammalian cells (APExBIO datasheet).
    • In human colonic epithelial models, neurotensin treatment (100 nM, 2 h, 37°C) increases miR-133α expression by >2-fold, as measured by qRT-PCR (internal review).
    • miR-133α targets AFTPH 3'UTR, reducing aftiphilin protein abundance and impairing NTR1 recycling, as validated by luciferase reporter assays and immunoblotting (internal technical perspective).
    • Purity of APExBIO’s Neurotensin B5226 is ≥98%, confirmed by reverse-phase HPLC and MALDI-TOF mass spectrometry, supporting consistent experimental outcomes (APExBIO).
    • Neurotensin is soluble at concentrations ≥15.33 mg/mL in DMSO and ≥22.55 mg/mL in water; insoluble in ethanol (tested at 25°C, neutral pH) (product data).
    • Recent advances in excitation–emission matrix (EEM) fluorescence spectroscopy and machine learning enable discrimination of peptide spectral signatures, minimizing pollen and environmental interference in bioaerosol or biosample analyses (Zhang et al., 2024).

    Applications, Limits & Misconceptions

    Neurotensin serves as a prototypical Neurotensin receptor 1 activator for:

    • Dissecting GPCR trafficking mechanisms in neural and gastrointestinal epithelial cells (previously discussed; this article updates with interference-mitigation protocols).
    • Elucidating miRNA-mediated post-transcriptional regulation in receptor recycling and signal adaptation.
    • Modeling microRNA network perturbations in gastrointestinal physiology and pathology.
    • Providing a validated reagent for fluorescence-based receptor localization and trafficking assays, enabled by high purity and solubility.

    Common Pitfalls or Misconceptions

    • Neurotensin is not active at all GPCRs; its specificity is highest for NTR1 and related neurotensin receptors, not generic peptide GPCRs.
    • Long-term storage of reconstituted peptide solutions is not recommended; hydrolysis or aggregation may compromise activity even at -20°C.
    • Solubility in ethanol is negligible; use DMSO or water for all experimental preparations.
    • Environmental fluorescence (e.g., pollen spectral interference) may confound spectral assays if not properly controlled—recent EEM-ML protocols mitigate this risk (Zhang et al., 2024).
    • miR-133α modulation by neurotensin is context-dependent; not all cell types show identical regulatory responses.

    Workflow Integration & Parameters

    • Reconstitution: Dissolve neurotensin at ≥15.33 mg/mL in DMSO or ≥22.55 mg/mL in sterile water at room temperature (20–25°C).
    • Aliquoting: Prepare small aliquots to avoid repeated freeze-thaw cycles.
    • Storage: Store lyophilized product desiccated at -20°C. Use reconstituted solutions immediately; do not store long-term.
    • Purity confirmation: Each lot is tested by HPLC and mass spectrometry to ensure ≥98% purity.
    • Spectral controls: Employ EEM fluorescence and machine learning-based spectral discrimination to control for environmental interference, especially in complex bioaerosol or heterogeneous samples (Zhang et al., 2024).

    For extended protocols and troubleshooting details, see the APExBIO Neurotensin (CAS 39379-15-2) B5226 product page.

    Conclusion & Outlook

    Neurotensin (CAS 39379-15-2) is a precision reagent for dissecting the molecular mechanisms of GPCR trafficking and miRNA regulation in both gastrointestinal and neural research. The validated purity, robust solubility, and optimized storage conditions of APExBIO’s B5226 product enable reproducible, interference-resistant experiments. Advances in spectral analysis and machine learning approaches further strengthen the reliability of neurotensin-based workflows by minimizing confounders such as environmental fluorescence. For future directions, integration with high-throughput screening and single-cell transcriptomics may further expand its utility in translational bioscience. This article expands on previous resources by incorporating best-practice protocols for spectral interference control and updated evidence benchmarks.